Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes.
Journal: Journal of diabetes science and technology
Published: May 30, 2025
Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus.
Journal: Research square
Published: February 24, 2025
Advanced Glycation End Products (AGEs) Webinar Meeting Report.
Journal: Journal of diabetes science and technology
Published: November 07, 2024
A novel, centrally acting mammalian aminosterol, ENT-03, induces weight loss in obese and lean rodents.
Journal: Diabetes, obesity & metabolism
Published: July 06, 2024
Challenges and recommendations for the translation of biomarkers of aging.
Journal: Nature aging
Published: January 10, 2024
A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective.
Journal: Diabetologia
Published: June 20, 2023
Exercise-Induced Vision Dysfunction Early After Sport-Related Concussion Is Associated With Persistent Postconcussive Symptoms.
Journal: Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine
Published: April 04, 2023
Biomarkers of aging for the identification and evaluation of longevity interventions.
Journal: Cell
Published: March 24, 2023
Diabetes Technology Meeting 2022.
Journal: Journal of diabetes science and technology
Published: January 27, 2023
Efficacy and safety of Tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2/3 study.
Journal: Expert opinion on pharmacotherapy
Published: November 10, 2022
Oral insulin (ORMD-0801) in type 2 diabetes mellitus: A dose-finding 12-week randomized placebo-controlled study.
Journal: Diabetes, obesity & metabolism
Published: February 09, 2022
PATAS, a First-in-Class Therapeutic Peptide Biologic, Improves Whole-Body Insulin Resistance and Associated Comorbidities In Vivo.
Journal: Diabetes
Published: January 20, 2022
Last Updated: 09/26/2026